Table 1.
Angioedema (n = 145) | ACE inhibitor-exposed controls (n = 280) | P value | |
---|---|---|---|
Age, years | 57.8 ± 14.2 | 58.1 ± 11.4 | 0.83 |
Gender, M:F (%)* | 62 (43) : 83 (57) | 142 (51) : 138 (49) | 0.12 |
Race, B:W:other* | 74 (51) : 71 (49) : 0 | 135 (48) : 143 (51) : 2 (1) | 0.53 |
Transplant at presentation, N (%) | 9 (6.2) | 1 (0.4) | <0.001 |
Smokers, N (%)† | 35 (25.7) | 41 (14.8) | 0.007 |
Diabetes, N (%)† | 47 (32.4) | 105 (37.6) | 0.29 |
Seasonal allergies, N (%)† | 72 (67.9) | 127 (45.5) | <0.001 |
ACE, angiotensin-converting enzyme.
Mean ± standard deviation unless otherwise noted.
Controls were prespecified to be 50% black Americans and 50% white Americans and 50% female.
Percentage among those subjects for whom data were available.